For the first time, researchers have unravelled the complex structure of the inner protein shell of HIV. The US team, reporting in Nature, also worked out exactly how all the components of the shell or 'capsid' fit together at the atomic level. Until now the exact structure had proved elusive because of the capsid's large size and irregular shape. However, now the structure has been identified, the finding opens the way for new types of drugs, according to the researchers from Pittsburgh.
It was already known that the capsid, which sits inside the outer membrane of the virus, was a cone-shaped shell made up of protein-units in a lattice formation. But because it is huge, asymmetrical and non-uniform, standard techniques for working out the structure have proved ineffective. The team used advanced imaging techniques and a supercomputer to calculate how the 1,300 proteins which make up the cone-shaped capsid fit together.
The process revealed critical interactions between molecules in areas that are necessary for the shell's assembly and stability. These potential vulnerabilities in the protective coat of the viral genome could be exploited by scientists designing new drugs to tackle the problem of HIV resistance, the researchers explained.
Study leader Dr Peijun Zhang, associate professor of structural biology at the University of Pittsburgh School of Medicine said: "The capsid is critically important for HIV replication, so knowing its structure in detail could lead us to new drugs that can treat or prevent the infection." Sh
e went on to say: "The capsid has to remain intact to protect the HIV genome and get it into the human cell, but once inside, it has to come apart to release its content so that the virus can replicate. Developing drugs that cause capsid dysfunction by preventing its assembly or disassembly might stop the virus from reproducing."
Prof Simon Lovell, a structural biologist at the University of Manchester, said not only had the researchers managed to achieve something that was very difficult, but had also found some really interesting results. He explained how HIV treatment is made problematic by the way it evolves so quickly, but this new knowledge could allow the creation of an entirely new class of drugs, to be used alongside the existing class in a multi-drug cocktail.
Jack
Friday, 31 May 2013
Saturday, 25 May 2013
Cancer cell enzymes aid immune system
Enzymes released by cancerous cells have a protective function and are not one of the "bad guys", according to researchers from the University of East Anglia. The study they conducted found that the MMP-8 enzyme sent a signal to the immune system to attack the tumour; and patients whose breast tumours have more of this enzyme seem to do better.Scientists from UEA worked with clinicians at the Norfolk and Norwich University Hospital to look in detail at the patterns of MMPs in breast tumours from patients. Their study, published in the Journal of Biological Chemistry, reveals that the matrix metalloproteinase-8 enzyme (MMP-8) could be acting as the 'good guy' by alerting the immune system to the location of the tumour. It was previously thought that the production of MMPs by breast cancer cells helped to promote the growth of cancer. Drugs used to treat cancer in the 1990s, which blocked these enzymes, failed in the clinic, and this new research may explain why.
Prof Dylan Edwards, lead researcher from UEA's School of Biological Sciences, said that if breast cancer cells produce MMP-8 it causes them to produce two other inflammatory factors (IL-6 and IL-8) that have previously been shown to promote cancer. He said: "They were once thought to act like 'molecular scissors' to snip away at the scaffolding structures outside cells and clear a path for the cancer cells to invade and spread to other organs. However, breast tumour cells that over-produce MMP-8 don't survive long-term - the enzyme stops them growing." He went on to say: "We now think that in tumours, MMP-8 acts as a sort of 'find me' signal to the immune system, which then becomes activated to attack the tumour, which may help to explain its protective function."
It is still not known exactly how MMP-8 causes IL-6 and IL-8 to be activated, finding this out will be an important step forward which will help direct future research.
Dr Emma Smith, senior science information officer at Cancer Research UK, said: "This study provides very early clues as to how the MMP-8 protein may actually play the role of 'good cop' and recruit immune cells to fight breast cancer. And, rather than seeing the MMP-8 protein as a 'bad cop' in breast cancer, recent research has shown that levels of this protein are raised in women who do relatively well."
However these are early findings from cells grown in a lab, and more research will be required to see if the molecules found by the scientists alert immune cells to cancers in women.
Jack
Friday, 17 May 2013
Time-lapse embryo imaging improves IVF
According to \British research, time-lapse imaging which takes pictures of developing embryos can boost the success rate of IVF. The technique, reported in Reproductive BioMedicine Online, can be used to select embryos that have a low risk of defects.Scientists at the CARE fertility group say such informed selection can improve birth rates by 56%. Other experts say the result is exciting, but the study of 69 couples is too small to be definitive. The research followed the couples at the CARE fertility clinic in Manchester last year, when 88 embryos were imaged and implanted.
The embryos were put into an incubator and imaged every 10-20 minutes. They were then classed as low, medium or high risk of chromosome abnormalities based on their development at certain key points. Eleven babies were born from the low risk group (61% success rate) compared to five from the medium risk group (19% success rate) and none from those which were deemed to be high risk.
Prof Simon Fishel, managing director of CARE fertility group, said: "In the 35 years I have been in this field this is probably the most exciting and significant development that can be of value to all patients seeking IVF." He went on to say: "This technology can tell us which embryo is the most viable and has the highest potential to deliver a live birth - it will have huge potential. This is almost like having the
embryo in the womb with a camera on them."
In standard IVF, embryos are removed from the incubator once a day to be checked under the microscope. This means they briefly leave their temperature-controlled environment and single daily snapshots of their development are possible. However, if the time-lapse method is used, the embryos don't leave the incubator until they are implanted allowing 5,000 images to be taken.
Dr Virginia Bolton, from the assisted conception unit at Guy's and St Thomas' NHS Foundation Trust, commented: "Removing embryos from the incubator potentially exposes them to damage, so it must be a good thing to be able to look at the pattern of development over time." She also said: "These results are very interesting but this is a very small study and any interpretation of the findings must be made with caution as we are dealing with the hopes and expectations of patients."
Despite having the potential to improve embryo selection and thus success in fertility treatment, this is only a small study and much more research will be required before this becomes a routine clinical tool.
Jack
Saturday, 11 May 2013
Mosquito parasite resistance
Researchers have discovered a strain of bacteria that can infect mosquitoes and make them resistant to the malaria parasite. The study, in the journal Science, showed the parasite struggled to survive in infected mosquitoes. The study took place at Michigan State University and looked at the Wolbachia bacterium, which commonly infects insects. Malaria is spread between people by the insects so it is hoped that giving mosquitoes malaria immunity could reduce human cases.The bacterium passes only from females to their offspring, in some insects the bug is exceptionally good at manipulating insects to boost the number of females for its own ends. Wolbachia kills male embryos in some butterflies and ladybirds. In other situations, it can produce males that can only breed with infected females, and even allows some female wasps to give birth without mating.
Malaria-carrying Anopheles mosquitoes are not naturally affected by Wolbachia, but laboratory studies have shown that temporary infection made the insects immune to the malaria parasite. The challenge for the researchers was to turn a temporary infection into one that was passed on. They found a strain of Wolbachia that could persist in one species of mosquito, Anopheles stephensi, for the entire length of the study - 34 generations. Malaria parasites found it difficult to cope in these mosquitoes, with parasite levels fourfold lower than in uninfected bugs.
Research in Australia has shown that a different strain of Wolbachia can prevent the spread of dengue fever by mosquitoes. That research is more advanced and has been shown to work in large trials in the wild. Dr Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases in the US, said this study was a proof of concept that the same could be done for malaria.
Commenting on the study, Prof David Conway, of the London School of Hygiene and Tropical Medicine, said: "It is interesting and is the first report of Wolbachia clearly replicating, but a number of things took away the punch." He said the infected females produced fewer eggs than uninfected females, which meant the Wolbachia infection would struggle to spread in the real world. Also he cautioned that it was in just one species, Anopheles stephensi, which carries malaria in the Middle East and South Asia. Anopheles gambiae, in Africa, is a bigger problem. One of the researchers, Dr Zhiyong Xhi, said: "We have done only one strain. If we target Anopheles gambiae we would need to apply the same technique again." He added that if it could be shown to work then the 'Wolbachia tool' would need to be used in conjunction with currently available tools, such as mosquito nets and medication.
Jack
Friday, 3 May 2013
Scientists decode "molecular chatter" that causes spread of cancer cells
For the first time, US scientists have decoded the "molecular chatter" that makes cancer cells more aggressive and more likely to form tumours in other parts of the body. The discovery occurred as a result of bringing together specialists in cancer development with specialists in wound healing.
Principal investigator Prof Russell Taichman, from the University of Michigan, and colleagues, wrote about their discovery in the online issue of Nature Communications.
It is becoming increasingly clear that cancer cells are well-travelled adversaries that are capable of side-stepping the treatments we throw at them to try and stop their spread. For instance, a recent study that produced a catalogue of the physical properties of cancer cells, found they are nimbler and more aggressive than healthy cells because they are better able to pass through small spaces, and they exert a greater force on their environment. Now Taichman and colleagues have discovered a set of molecular signals that causes them to go into overdrive and spread.
For some time, scientists have known that tumours summon the body's healing cells, which is a major reason cancer is difficult to treat. A cancerous tumour acts like a wound that just won't heal: just like a benign tumour it sends out distress signals that recruit mesenchymal stem cells (MSCs) to heal it. These stem cells are then able to turn into several types of cell depending on the specific signals sent by the tumour. What Taichman and colleagues discovered is that when MSCs and cancer cells interact, the molecular messages that pass between them appear to send the cancer cells into overdrive and increase their ability to metastasise. He and his colleagues believe theirs is the first known study to explain molecular behaviour behind the series of changes that happen in the healing cells that result in cancer spread.
The interaction they decoded starts with a signal called CXCR6, which triggers the conversion of MSCs into fibroblasts, setting off a cascade that boosts metastasis:
Jack
Principal investigator Prof Russell Taichman, from the University of Michigan, and colleagues, wrote about their discovery in the online issue of Nature Communications.
It is becoming increasingly clear that cancer cells are well-travelled adversaries that are capable of side-stepping the treatments we throw at them to try and stop their spread. For instance, a recent study that produced a catalogue of the physical properties of cancer cells, found they are nimbler and more aggressive than healthy cells because they are better able to pass through small spaces, and they exert a greater force on their environment. Now Taichman and colleagues have discovered a set of molecular signals that causes them to go into overdrive and spread.
For some time, scientists have known that tumours summon the body's healing cells, which is a major reason cancer is difficult to treat. A cancerous tumour acts like a wound that just won't heal: just like a benign tumour it sends out distress signals that recruit mesenchymal stem cells (MSCs) to heal it. These stem cells are then able to turn into several types of cell depending on the specific signals sent by the tumour. What Taichman and colleagues discovered is that when MSCs and cancer cells interact, the molecular messages that pass between them appear to send the cancer cells into overdrive and increase their ability to metastasise. He and his colleagues believe theirs is the first known study to explain molecular behaviour behind the series of changes that happen in the healing cells that result in cancer spread.
The interaction they decoded starts with a signal called CXCR6, which triggers the conversion of MSCs into fibroblasts, setting off a cascade that boosts metastasis:
"CXCR6 signalling stimulates the conversion of mesenchymal stem cells into cancer-associated fibroblasts, which secrete stromal-derived factor-1, also known as CXCL12. CXCL12 expressed by cancer-associated fibroblasts then binds to CXCR4 on tumour cells and induces an epithelial-to-mesenchymal transition, which ultimately promotes metastasis to secondary tumour sites."This unique result was made possible because half of the researchers that worked on the study are experts in tumour development, and the other half are experts on wound healing. It came about because research associate Younghun Jung, who works in Taichman's lab and is first author of the paper, works in both fields. Taichman explains that it was her who put the two together and came up with the idea. Therefore this study is a good example of how surprising and useful discoveries in research can result from multidisciplinary work.
Jack
Subscribe to:
Posts (Atom)
